Clinical Trial Update: Imipenem-Relebactam Pharmacokinetics in Augmented Renal Clearance [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of imipenem-cilastatin/relebactam in patients with augmented renal clearance in the setting of sepsis; results were posted on 2024…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Imipenem/Cilastatin/Relebactam (imipenem/cilastatin/relebactam)

Snippet

Sponsor: Hartford Hospital | Conditions: Sepsis | Phase 1 | Status: COMPLETED | Results posted: 2024-08-06